【重大事项】
瑞科生物-B(02179)新佐剂重组九价HPV疫苗REC604c中国临床试验申请获得受理
微创机器人-B(02252)：图迈单臂单孔腔镜手术机器人获国家药监局注册批准
丽珠医药(01513)获批准注射用 JP-1366 开展临床试验
先健科技(01302)：主动脉覆膜支架系统获得中国国家药品监督管理局的正式注册批准
伟仕佳杰(00856)附属佳杰云星的AI算力管理与调度平台 实现与DeepSeek系列大模型适配
理士国际(00842)拟分拆Leoch Energy Inc.在美国证券交易所单独上市
【财报数据】
舜宇光学科技(02382)发盈喜 预期2024年度股东应占溢利约26.39亿元至27.49亿元 同比增加约140.0%至150.0%
欧康维视生物-B(01477)预计2024年度收益同比增长65.6%-70.5%
舜宇光学科技(02382)1月手机镜头出货量约1.06亿件，同比增长2.6%
中国电力(02380)2024年度合并总售电量为1.28亿兆瓦时 同比增加23.94%
如需了解更多详情，请参阅智通财经网(www.zhitongcaijing.com)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.